GS CAPSULE Trademark

Trademark Overview


On Monday, April 8, 2024, a trademark application was filed for GS CAPSULE with the United States Patent and Trademark Office. The USPTO has given the GS CAPSULE trademark a serial number of 98489249. The federal status of this trademark filing is REQUEST FOR EXTENSION OF TIME TO FILE OPPOSITION as of Thursday, January 2, 2025. This trademark is owned by Shanxi Guangsheng Medicinal Capsule Co., Ltd.. The GS CAPSULE trademark is filed in the Pharmaceutical Products category with the following description:

Analgesic preparations; Capsules made of dendrimer-based polymers sold empty for pharmaceuticals; Capsules sold empty for pharmaceuticals; Gelatin capsules sold empty for pharmaceuticals; Herbs for medicinal purposes; Medicinal herbs; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations, namely, dantrolene sodium for injection; Pharmaceuticals, namely, anti-infectives; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders
gs capsule

General Information


Serial Number98489249
Word MarkGS CAPSULE
Filing DateMonday, April 8, 2024
Status802 - REQUEST FOR EXTENSION OF TIME TO FILE OPPOSITION
Status DateThursday, January 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 17, 2024

Trademark Statements


Description of MarkThe mark consists of the stylized wording "GS capsule" with a design logo of two intersecting hearts..
Goods and ServicesAnalgesic preparations; Capsules made of dendrimer-based polymers sold empty for pharmaceuticals; Capsules sold empty for pharmaceuticals; Gelatin capsules sold empty for pharmaceuticals; Herbs for medicinal purposes; Medicinal herbs; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations, namely, dantrolene sodium for injection; Pharmaceuticals, namely, anti-infectives; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"CAPSULE"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 8, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameShanxi Guangsheng Medicinal Capsule Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJinzhong, Shanxi 030600
CN

Party NameShanxi Guangsheng Medicinal Capsule Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJinzhong, Shanxi 030600
CN

Trademark Events


Event DateEvent Description
Monday, April 8, 2024NEW APPLICATION ENTERED
Tuesday, September 10, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, September 10, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 17, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 17, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, October 17, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, October 17, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, October 17, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, October 17, 2024ASSIGNED TO EXAMINER
Wednesday, December 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 17, 2024PUBLISHED FOR OPPOSITION
Thursday, January 2, 2025EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, December 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED